区分儿童期与成年期体型对炎症性关节炎的影响:一项孟德尔随机化研究
该研究采用孟德尔随机化方法,利用英国生物银行453 169名个体的遗传工具变量及22 350例类风湿关节炎、9069例强直性脊柱炎、3609例银屑病关节炎、13 179例痛风和5201例系统性红斑狼疮的基因组关联数据,分析儿童期体型在考虑成年期体型后对上述疾病风险的独立影响。结果显示儿童期体型对银屑病关节炎、痛风和系统性红斑狼疮有总效应,对类风湿关节炎和强直性脊柱炎无效应;考虑成年期体型后,银屑病关节炎和系统性红斑狼疮的直接效应变化不大,痛风则减弱。结论提示银屑病关节炎和系统性红斑狼疮中儿童期较大体型带来的风险即使成年后达到健康体型也可能无法完全逆转。
要点
- 儿童期体型对银屑病关节炎、痛风和系统性红斑狼疮有总效应,对类风湿关节炎和强直性脊柱炎无效应。
- 考虑成年期体型后,儿童期体型对银屑病关节炎和系统性红斑狼疮的直接效应变化不大,对痛风则减弱。
- 银屑病关节炎和系统性红斑狼疮中儿童期较大体型带来的风险即使成年后达到健康体型也可能无法完全逆转。
核心结论
- 研究提示,对于银屑病关节炎和系统性红斑狼疮,儿童期较大体型带来的风险即使成年后达到健康体型也可能无法完全逆转。
研究设计与样本
- 采用孟德尔随机化方法,儿童期(10岁)和成年期体型的遗传工具变量分别基于英国生物银行453 169名个体的313和580个变异,并已在三个独立人群中用体重指数数据验证。
- 基因组关联数据包括22 350例类风湿关节炎、9069例强直性脊柱炎、3609例银屑病关节炎、13 179例痛风和5201例系统性红斑狼疮病例。
- 对每个结局进行单变量孟德尔随机化估计儿童期和成年期体型的总效应,并进行多变量孟德尔随机化分析考虑成年期体型后儿童期体型的独立效应。
主要发现
- 遗传预测的儿童期体型对银屑病关节炎有总效应(OR 2.18每体型类别变化;95%CI 1.43至3.31)。
- 遗传预测的儿童期体型对痛风有总效应(OR 2.18;95%CI 1.43至3.31)。
- 遗传预测的儿童期体型对系统性红斑狼疮有总效应(OR 2.44;95%CI 1.14至5.22)。
- 遗传预测的儿童期体型对类风湿关节炎无总效应(OR 0.95;95%CI 0.70至1.29),对强直性脊柱炎无总效应(OR 0.96;95%CI 0.61至1.52)。
- 考虑成年期体型后,儿童期体型的直接效应对银屑病关节炎变化不大(OR 1.92;95%CI 1.14至3.25),对系统性红斑狼疮变化不大(OR 2.69;95%CI 1.24至5.87),对痛风则减弱(OR 1.40;95%CI 0.94至2.09)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Using Mendelian randomisation (MR), we examined whether childhood body size affects risk of rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA), gout and systemic lupus erythematosus (SLE) after accounting for the effect of adult body size. METHODS: Genetic instruments for childhood (age 10 years) and adult body size were derived using data from 453 169 individuals from the UK Biobank study (313 and 580 variants respectively), which have been previously validated using body mass index data from three independent populations. Genome-wide association data comprised 22 350 RA, 9069 AS, 3609 PsA, 13 179 gout and 5201 SLE cases. For each outcome, we conducted univariable MR to estimate the total effects of childhood and adult body size, and multivariable MR to examine the independent effect of childhood body size after accounting for adult body size. RESULTS: Genetically predicted childhood body size had a total effect on risk of PsA (OR 2.18 per change in body size category; 95% CI 1.43 to 3.31), gout (OR 2.18; 95% CI 1.43 to 3.31) and SLE (OR 2.44; 95% CI 1.14 to 5.22), but not RA (OR 0.95; 95% CI 0.70 to 1.29) or AS (OR 0.96; 95% CI 0.61 to 1.52). After accounting for adult body size, the direct effect of childhood body size was little changed for PsA (OR 1.92; 1.14 to 3.25) and SLE (OR 2.69; 1.24 to 5.87) but was attenuated for gout (OR 1.40; 95% CI 0.94 to 2.09). CONCLUSIONS: Our findings suggest that, for PsA and SLE, the risk conferred from having a larger body size during childhood may not be fully reversable even when a healthy size is achieved in adulthood.
引用
- Zhao SS, Bowes J, Barton A, et al. Separating the effects of childhood and adult body size on inflammatory arthritis: a Mendelian randomisation study. RMD Open. 2022. PMID: 35995490. doi:10.1136/rmdopen-2022-002321
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。